Cinnamomum burmannii Bioactives as VEGFR-2 Inhibitors in Colon Cancer: A Chemoinformatics Approach
DOI:
https://doi.org/10.70392/jrn.v3i2.32Keywords:
Cinnamomum burmannii, colon cancer, computational studies, VEGFR-2Abstract
Colon cancer is among the most prevalent cancers globally, with its progression closely associated with angiogenesis, primarily mediated by the activation of vascular endothelial growth factor receptor 2 (VEGFR-2). Although VEGFR-2 inhibitors such as apatinib have demonstrated efficacy in colon cancer therapy, their clinical use is limited due to potential side effects and high treatment costs. Natural compounds from Cinnamomum burmannii, which are known to contain secondary metabolites including flavonoids, saponins, phenols, tannins, and sterols/triterpenoids, present a potential alternative. This study aims to evaluate the inhibitory potential of C. burmannii bioactive compounds against VEGFR-2 using a computational-based approach. The methodology involved Lipinski's rule of five (RO5) analysis, ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction, pharmacophore screening, and molecular docking simulations. Among the screened compounds, methylhydroxychalcone emerged as the most promising candidate, exhibiting a favorable binding affinity with a Gibbs free energy of −8.51 kcal/mol and an inhibition constant of 579.80 nM. It also fulfilled drug-likeness criteria and displayed a good pharmacokinetic profile. Notably, methylhydroxychalcone interacted with the Asp1046 residue on VEGFR-2, a key interaction site also targeted by Apatinib. These findings support the potential of cinnamon bark-derived compounds, particularly methylhydroxychalcone, as prospective VEGFR-2 inhibitors for colon cancer therapy.
References
Sanjaya, W.B.; Lestarini, A.; Bharata, M.D.Y.. Karakteristik klinis pada pasien kanker kolorektal yang menjalani kolonoskopi di RSUD Sanjiwani Gianyar tahun 2019-2020. Aesculapius Medical Journal, 3(1) 2020, 43-48. https://doi.org/10.22225/amj.3.1.2023.43-48
Siegel, R.L.; Giaquinto, A.N.; Jemal, A.. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1) 2024, 12-49. https://doi.org/10.3322/caac.21820
Izzaaturahmi, A.S.; Pauziah, A.S.U.; Virliana, A.; Sitinjak, G.M.L.; Ramadhiany, Z.Z.; Elaine, A.A.; Sitinjak, B.D.P.; Aulifa, D.L.. In silico study of licorice (Glycyrrhiza glabra L.) on VEGFR-2 receptors in breast cancer. Indonesian Journal of Biological Pharmacy, 3(3) 2023, 137-153. https://doi.org/10.24198/ijbp.v3i3.45597
Modi, S.J.; Kulkarni, V.M.. Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: Medicinal chemistry per-spective. Medicine in Drug Discovery 2019. https://doi.org/10.1016/j.medidd.2019.100009
Cai, X.; Wei, B.; Li, L.; Chen, X.; Yang, J.; Li, X.; Wang, H.; Zhang, Y.; Yang, Y.; Gu, Y.. Therapeutic potential of apatinib against colorectal cancer by inhibiting VEGFR2-mediated angiogenesis and β-catenin signaling. OncoTargets and Therapy, 13 2020, 11031-11044. https://doi.org/10.2147/OTT.S266549
Leng, J.; Li, D.; Huang, L.; Ji, X.; Wang, D.. Apatinib is effective as a third-line and more treatment of advanced metastatic non-small-cell lung cancer. Medicine, 98(36) 2019, e16967.
Aborziza, M.; Amalia, R.; Zuhrotun, A.; Ikram, N.K.K.; Novitasari, D.; Muchtaridi, M.. Coffee bean and its chemical constit-uent caffeine and chlorogenic acid as promising chemoprevention agents: Updated biological studies against cancer cells. Molecules, 29(14) 2024, 3302. https://doi.org/10.3390/molecules29143302
Tan, M.V.; Rorong, J.A.; Sangi, M.S.. Fotoreduksi besi Fe3+ menggunakan ekstrak daun kayu manis (Cinnamomum bur-mannii). Jurnal Ilmiah Sains, 18(1) 2018, 1-9. https://doi.org/10.35799/jis.18.1.2018.18821
Larasati, Y.A.; Meiyanto, E.. Revealing the potency of cinnamon as an anti-cancer and chemopreventive agent. Indonesian Jour-nal of Cancer Chemoprevention, 9(1) 2018, 47-62. https://doi.org/10.14499/indonesianjcanchemoprev9iss1pp47-62
Fajar, A.; Ammar, G.A.; Hamzah, M.; Manurung, R.; Abduh, M.Y.. Effect of tree age on the yield, productivity, and chemical composition of essential oil from Cinnamomum burmannii. Current Research on Biosciences and Biotechnology, 1(1) 2019, 17-22. https://doi.org/10.5614/crbb.2019.1.1/SCDI5665
Caserta, S.; Genovese, C.; Cicero, N.; Gangemi, S.; Allegra, A.. The anticancer effect of cinnamon aqueous extract: A focus on hematological malignancies. Life, 13(5) 2023, 1176. https://doi.org/10.3390/life13051176
Susilowati, A.; Herupradoto, E.B.A.; Luqman, E.M.; Kasman, A.A.M.N.; Budiarto, B.. Characterization of nano encapsulated cinnamon bark extract (Cinnamomum burmannii) based on chitosan alginate as a potential drug delivery system for cervical cancer therapy. GSC Biological and Pharmaceutical Sciences, 30(2) 2025, 135-141. https://doi.org/10.30574/gscbps.2025.30.2.0047
Indrayudha, P.; Hapsari, H.S.. Cytotoxic activity of combined ethanolic extract of Cinnamomum burmannii and Ocimum tenu-iflorum Linn against T47D cancer cells. Archivos Venezolanos de Farmacología y Terapéutica, 40(2) 2021, 114-125. https://doi.org/10.5281/zenodo.4708343
Larasati, Y.A.; Putri, D.D.P.; Utomo, R.Y.; Hermawan, A.; Meiyanto, E.. Combination of cisplatin and cinnamon essential oil inhibits HeLa cells proliferation through cell cycle arrest. Journal of Applied Pharmaceutical Science, 4(12) 2014, 14-19.
Pradeepkiran, J.A.; Shrikanya, K.; Sainath, S.B.. In silico validation and ADMET analysis for the best lead molecules. Academic Press 2021, 133-176. https://doi.org/10.1016/B978-0-323-85681-2.00008-2
Ismail, D.P.F.; Christella, A.; Salsabila, N.F.; Angelina, A.; Muljono, F.O.; Fardhani, F.M.; Novitasari, D.. The bioactive compounds in bilimbi leaves (Averrhoa bilimbi L.) as natural-based anticancer targeting on VEGFR-2: In silico studies. Notulae Scientia Biologicae, 17(1) 2025, 12289. https://doi.org/10.55779/nsb17112289
Meiyanto, E.; Novitasari, D.; Utomo, R.Y.; Susidarti, R.A.; Putri, D.D.P.; Kato, J.Y.. Bioinformatic and molecular interac-tion studies uncover that CCA-1.1 and PGV-1 differentially target mitotic regulatory protein and have a synergistic effect against leukemia cells. Indonesian Journal of Pharmacy, 33(2) 2022, 225-233.
Tafrihani, A.S.; Hanif, N.; Yoga, I.M.B.K.; Irmasari, I.; Fakih, T.M.; Novitasari, D.; Hasibuan, P.A.Z.; Satria, D.; Huda, F.; Muchtaridi, M.; Hermawan, A.. A computational study of cardiac glycosides from Vernonia amygdalina as PI3K inhibitors for targeting HER2-positive breast cancer. Journal of Computer-Aided Molecular Design, 39(1) 2025, 43. https://doi.org/10.1007/s10822-025-00621-4
Salsabila, R.; Simarmata, Y.V.; Simbolon, L.M.I.; Sianturi, L.R.; Gabriel, K.; Rusdin, A.; Novitasari, D.. Studi in silico sen-yawa dalam tanaman cengkeh (Syzygium aromaticum L.) sebagai kandidat antidiabetes tertarget pada reseptor PPARγ. Jurnal Ilmu Farmasi dan Farmasi Klinik, 21(2) 2024, 258-268.
Xiao, Y.; Hu, Z.; Yin, Z.; Zhou, Y.; Liu, T.; Zhou, X.; Chang, D.. Profiling and distribution of metabolites of procyanidin B2 in mice. Frontiers in Pharmacology, 8 2017, 231. https://doi.org/10.3389/fphar.2017.00231
Rachmawati, A.L.; Surini, S.. Formulasi dan karakterisasi nanopartikel sambungsilang gom xantan dan gom akasia untuk penghantaran insulin oral. Pharmaceutical Sciences and Research, 5(3) 2018, 159-168. https://doi.org/10.7454/psr.v5i3.4192
Mahrous, R.S.; Fathy, H.M.; Abu El-Khair, R.M.; Omar, A.A.; Ibrahim, R.S.. Molecular docking and pharmacophore model-ling: A bridged explanation with emphasis on validation. Journal of Applied Pharmaceutical Science, 1(1) 2024, 138-152. https://doi.org/10.21608/japs.2024.253925.1007
Almattin, B.N.; Aulifa, D.L.; Al Shofwan, A.A.. Kalkon dan potensinya sebagai antikanker: Literatur review. Jurnal Farmasi Klinik Indonesia, 11(4) 2022, 360-375. https://doi.org/10.15416/ijcp.2022.11.4.360
Lestari, I.N.; Renada, E.; Juliana, D.; Iswara, K.; Sukmara, S.. Molecular docking study of antidiabetic compounds on PPAR-γ receptors from ciplukan (Physalis angulata Linn.). Indonesian Journal of Biological Pharmacy, 3(1) 2023, 1-9. https://doi.org/10.24198/ijbp.v3i1.43355
Sun, Y.W.; Huang, W.J.; Hsiao, C.J.; Chen, Y.C.; Lu, P.H.; Guh, J.H.. Methoxychalcone induces cell-cycle arrest and apopto-sis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways. Prostate, 70(12) 2010, 1295-1306. https://doi.org/10.1002/pros.21165
Zhou, J.; Wan, F.; Xiao, B.; Li, X.; Peng, C.; Peng, F.U.. Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer. Oncology Research, 32(5) 2024, 943-953. https://doi.org/10.32604/or.2023.044775
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Zahra Aulia, Yasmine Ulayya Dhiya Iskandar, Nabilah Azzahra Frianjani, Dzava Prawinsyah Fairus Ismail, Bintang Satrio Mahardika, Dhania Novitasari (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




